Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Elara Health and Wellness vs Mevo Health

Elara Health and Wellness
Graded #33

Higher grade

vs+21.89999999999999
Mevo Health
Graded #326

Lower grade

The verdict

Elara Health and Wellness takes it — 82.1/100 to 60.2/100.

Elara Health and Wellness grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Low-ish both-molecule pricing ($117/$196), nationwide — but unverified.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueElara Health and Wellness +31
87
56
Dose & formulationMevo Health +3
80
83
Clinical oversightElara Health and Wellness +12
79
67
Labs & monitoringElara Health and Wellness +26
78
52
FulfillmentElara Health and Wellness +29
86
57
Contract termsElara Health and Wellness +62
82
20
Elara Health and Wellness · left barMevo Health · right bar

The numbers

MetricElara Health and WellnessMevo Health
WeighScore82.1/10060.2/100
GradeB−C
Scorecard rank#33#326
Semaglutide$117/mo$199/mo (all doses, compounded)
Tirzepatide$196/mo$259/mo (all doses, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
Elara Health and Wellness

Graded #33 · B−

Strengths

  • $117 semaglutide
  • All 50 states
  • Both molecules

Where it loses points

  • Not LegitScript-verified
  • Tirzepatide $196
  • Monitoring detail sparse
Mevo Health

Graded #326 · C

Strengths

  • LegitScript verification badge on multiple pages
  • Publishes the FDA compounded-medication disclaimer
  • Four named board-certified physicians disclosed (Wasef, Suppa, Sakla, Chikando)
  • Both semaglutide and tirzepatide in injection and oral-tablet forms — rare in DTC
  • Public entry-level pricing surfaced

Where it loses points

  • States served not listed on any public page
  • Pharmacy partners not named (only '503A U.S. compounding pharmacies' with unlabeled logos)
  • No formal Medical Director role disclosed
  • Only 'as low as' entry pricing shown — no per-dose itemization
  • No SOC 2 certification claimed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard